Biologics for Chronic Severe Asthma: a Network Meta-Analysis

Iain Crossingham,Rebekah Richardson,Timothy SC Hinks,Sally Spencer,Simon Couillard, Anne-Catherine Maynard-Paquette,Doranne Thomassen,Imran Howell

Cochrane library（2022）

引用 0|浏览8

暂无评分

摘要

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of biological agents targeting type‐2 inflammation (benralizumab, dupilumab, mepolizumab, omalizumab, reslizumab, tezepelumab) in people with severe asthma, with a network meta‐analysis and to rank agents by effectiveness.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要